FDA.MI - Fidia S.p.A.

Milan - Milan Delayed price. Currency in EUR
-0.07 (-1.03%)
At close: 5:35PM CEST
Stock chart is not supported by your current browser
Previous close6.30
Bid6.17 x 30000
Ask6.30 x 18200
Day's range6.20 - 6.34
52-week range4.77 - 7.57
Avg. volume6,197
Market cap31.85M
PE ratio (TTM)22.09
EPS (TTM)0.28
Earnings dateN/A
Forward Dividend & YieldN/A (N/A)
Ex-dividend dateN/A
1y target est7.30
  • Business Wire3 months ago

    FIDIA PHARMA USA Inc. Continues to Expand U.S. Presence as Fidia Farmaceutici S.p.A. Leads European Orthopedic Biomaterials Market

    Fidia Farmaceutici S.p.A., a world leader in the research, development and manufacturing of hyaluronan (HA)-based products, and its wholly owned subsidiary, FIDIA PHARMA USA Inc., are projecting continued growth in 2017. The global viscosupplementation market is anticipated to increase to over $2.64 billion by 2021, according to a research study by RnR Market Research1. Fidia Farmaceutici S.p.A. now leads the orthopedic biomaterials market in Europe after increasing its market share over the past few years.

  • We're sorry this is all we were able to find about this topic.

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes